XOMA Corporation (XOMA)
NASDAQ: XOMA · IEX Real-Time Price · USD
28.06
+0.65 (2.37%)
At close: Jul 19, 2024, 4:30 PM
28.10
+0.04 (0.14%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Company Description

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific.

It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates.

The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets.

It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024.

XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

XOMA Corporation
XOMA Corporation logo
Country United States
Industry Biotechnology
Sector Healthcare
Employees 13
CEO Owen P. Hughes Jr.

Contact Details

Address:
2200 Powell Street, Suite 310
Emeryville, California 94608
United States
Phone 510-204-7239
Website xoma.com

Stock Details

Ticker Symbol XOMA
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000791908
CUSIP Number 98419J206
ISIN Number US98419J2069
Employer ID 52-2154066
SIC Code 2834

Key Executives

Name Position
Owen P. Hughes Jr. Chief Executive Officer and Director
Thomas M. Burns Senior Vice President of Finance and Chief Financial Officer
Brad Sitko Chief Investment Officer

Latest SEC Filings

Date Type Title
Jul 9, 2024 8-K Current Report
Jun 17, 2024 EFFECT Notice of Effectiveness
Jun 17, 2024 EFFECT Notice of Effectiveness
Jun 13, 2024 8-K/A [Amend] Current report
May 30, 2024 8-K Current Report
May 16, 2024 8-K Current Report
May 9, 2024 8-K Current Report
May 9, 2024 10-Q Quarterly Report
Apr 30, 2024 8-K Current Report
Apr 25, 2024 8-K Current Report